29th December 2021 | Pharma Updates
Drug firms all set to launch Molnupiravir
Cipla, DRL and Sun Pharma will soon bring molnupiravir capsules in the Indian market.
Sun Pharma gets DCGI nod for Molxvir
Pharma firm stated that Molxvir will be available to patients at an affordable price.
India seeking to advance Medtech and domestic pharma ecosystem with improved guidelines
India’s Department of Pharmaceuticals has presented new guidelines to boost medical device and pharma industries.
5 Career Options After Pharma
There are many lucrative opportunities such as pharma sales representatives, Regulatory Specialists, Research Scientists, Clinical Data Managers and Biotechnology consultants.
Sun Pharma to Set Up Production Unit In AP
Sun Pharma MD said he is happy to discuss this development with the CM of the state.
Granules gets FDA approval for Generic Version of Prazosin Hydrochloride Capsules
US FDA granted nod to the generic Prazosin Hydrochloride capsules, of strengths 1mg, 2mg and 5 mg.
FDA okays Lupin's Generic Tablets to Treat BP
These tablets are generic edition of Edarbi tablets, 40 mg and 80 mg of Arbor Pharma.